SEC Filing Timeline
Recent News (Finnhub)
UFC Hall of Famer Michael Bisping Backs Xycota Biosciences' Low-Dose Psilocybin Research on PTSD and Concussion
BioAdaptives Acquisition Target Xycota Biosciences Launches Free PTSD Tactical & Support Hub for Veterans and First Responders …
BioAdaptives to Acquire Xycota Biosciences to Pursue the Potential of At Home Psilocybin Treatment